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Regulation by the 59 Untranslated Region
Translation initiation is generally the rate limiting step
Over twenty years ago, an obligatory role for protein
in the overall process and is influenced by elements
translation in G1 cell cycle progression was brought to
within the 59 untranslated region (UTR) of the mRNA.
light (reviewed by Norbury and Nurse, 1992). Transit The rapamycin-sensitive translation of an IGF-II mRNA
through the cell cycle is thought to require a general appears to be regulated by such a mechanism. Tran-
increase in the rate of translation following growth fac- scripts of the hormone IGF-II are alternatively spliced
tor-stimulation; in fact, even a partial inhibition of protein to produce multiple mRNAs that differ only in their 59
synthesis causes fibroblasts to accumulate in the G1 UTRs. The translation of two such splice variants (4.8
phase (Norbury and Nurse, 1992). It is now well known and 6.0 kb) are discordant in their sensitivity to rapa-
that growth factor stimulation causes a 2-3 fold mean mycin treatment. While the 4.8 kb message is translated
increase in overall protein synthesis, implicating trans- equally in rapamycin treated and untreated cells, trans-
membrane signaling events in translational control (re- lation of the 6.0 kb transcript is both rapamycin-sensitive
viewed by Sonenberg, 1996). This average increase ap- and dependent on the presence of growth factors (Niel-
pears modest; however, while translation of some sen et al., 1995). Thus, the 1.2 kb leader sequence in
transcripts remains unaffected by mitogen stimulation, the 59 UTR of the 6.0 kb variant confers translational
others increase greatly (discussed below). Although our regulation to this gene.
understanding of the events that regulate gene expres- What structural elements in 59 UTRs may be involved
sion through transcription has made steady progress, in their translational regulation? One element implicated
the signal transduction pathways involved in transla- in the regulated translation of transcripts encoding ribo-
tional control have remained relatively uncharacterized. somal proteins and the eukaryotic elongation factors 1A
Catalyzed through use of cell-permeable inhibitors of and 2 (eEF1A and eEF2) is the polypyrimidine tract. This
cell cycle progression, one signaling pathway that leads 59 terminal oligopyrimidine tract (59 TOP) typically con-
to translational control has recently become better un- sists of a stretch of 4-14 pyrimidines following the N7-
derstood. This pathway is distinct from now well known methylguanosine cap structure of the mRNA. Transla-
ras/MAP kinase and Jak/Stat pathways that, among tional regulation of the ribosomal protein S16 transcript
other outcomes, are involved in membrane-to-nuclear is abolished by replacement of five pyrimidines with
signaling events. purines in the 59 UTR (Levy et al., 1991). A short stretch
Rapamycin, initially characterized as an inhibitor of of pyrimidines is also found within 139 bp of the cap
G1 cell cycle progression, has recently been used to site of the 6.0 kb IGF-II transcript. Therefore, 59 TOP
illuminate a growth factor-regulated signaling pathway tracts are candidate translational cis-regulatory ele-
that leads to the enhanced translation of a specific sub- ments, TLREs (Levy et al., 1991), that may be modulated
set of mRNAs. Translation of most transcripts is unaf- by the rapamycin-sensitive signaling pathway.
fected by the presence of rapamycin (Jefferies et al., However, there are other structural elements in the 59
1994; Terada et al., 1994; Nielsen et al., 1995). In fact, UTR of mRNAs that are known to influence translation
treatment with rapamycin for 2-3 hours has only a slight initiation. It has been speculated that regulation of tran-
inhibitory effect (15%) on overall protein synthesis (Jef- scripts with long 59 UTRs is due to the formation of
feries et al., 1994; Terada et al., 1994; Mendez et al., secondary structures that must be overcome to provide
1996). However, translation of mRNAs derived from a efficient translation initiation (Sonenberg, 1996). In sup-
few genes is inhibited significantly. The gene transcripts port of this hypothesis, sequences that form stable sec-
thus far identified as being rapamycin-sensitive include ondary structures (DG#264 kcal/mol) efficiently inhibit
those encoding ribosomal proteins (S3, S6, S14, and translation when inserted into the 59 UTR (Sonenberg,
S24), translation elongation factors (eEF1A and eEF2), 1996, and references therein). Examples of transla-
and a secreted peptide growth factor called insulin-like tionally-regulated mRNAs with long and complex 59
growth factor II (IGF-II). As indicated by an increased UTRs include those that encode human FGF-5, c-myc
association with multiple ribosomes (polyribosomes), and ornithine decarboxylase (Sonenberg, 1996). It is
these rapamycin-sensitive transcripts are translated at possible then that formation of stable secondary struc-
a 2-10 fold increased rate following mitogen stimulation tures within the 59 UTR of some transcripts, like that of
(Jefferies et al., 1994; Terada et al., 1994; Nielsen et IGF-II, may confer translational regulation that is depen-
al., 1995). This shift to polyribosomes occurs with a dent on rapamycin-sensitive signaling pathway. Such a
concomitant decrease in the level of these mRNAs in hypothesis is supported by recent findings concerning
the function of the eukaryotic initiation factor 4E (eIF4E).ribonuclear protein (mRNP) particles, a putative storage
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Figure 1. A Schematic Representation of the
Growth Factor-Regulated Signaling Pathway
that Leads to Translation Control
Transmembrane signaling events, involving
the activation of phosphatidylinositol-3 ki-
nase (PI3K) and phospholipase C-g (PLCg),
mediate activation of p70 S6 kinase (p70S6k)
and phosphorylation of the eukaryotic ini-
tiation factor 4E (eIF4E) binding protein,
4E-BP1. Although not likely to be direct sub-
strates for FRAP, both the activation of p70S6k
by phosphorylation and the phosphorylation
of 4E-BP1 are dependent on FRAP kinase
activity, an activity inhibited by the FKBP12–
rapamycin complex. Activated p70S6k phos-
phorylates the protein S6 in the 40S ribo-
somal subunit, an event that is correlated with
growth factor-regulated increases in transla-
tion. Phosphorylation of 4E-BP1 prevents its
inhibitory association with eIF4E. Translation
initiation is catalyzed through the association
of a complex of eIF4 initiation factors, includ-
ing eIF4E and the RNA helicase eIF4A, with
the N7-methylguanosine (m7G) cap on the
mRNA. Transcripts that contain secondary
structure in the 59 untranslated region may
be especially dependent on the association
of the eIF4 complex.
Regulation of Translation Initiation Components the S6 protein in the 40S ribosomal subunit (reviewed
by Chou and Blenis, 1995). Phosphorylation of S6 hasThe initiation factor eIF4E is part of a complex of initia-
tion factors (including eIF4A, eIF4B and eIF4G) that as- long been known to correlate with the increased transla-
tion observed following mitogen stimulation. Moreover,semble on the mRNA cap site and possess an RNA
helicase activity. The eIF4E binds directly to the N7- ribosomes that contain a phosphorylated S6 protein are
engaged in translation as polyribosomes a greater per-methylguanosine cap structure of mRNA, providing a
means for assembly of eIF4A, B, and G subunits on the centage of the time than ribosomes in which S6 is not
phosphorylated. Rapamycin treatment causes the rapid59 end of mRNA (for further review see Sonenberg,
1996). Accumulation of these initiation factors on RNA inactivation of p70S6k and the dephosphorylation of S6
in vivo (reviewed by Chou and Blenis, 1995). However,is speculated to unwind secondary structures in the 59
untranslated regions of mRNA and thereby allow effi- since rapamycin does not affect translation generally
but rather significantly inhibits only the translation of acient translation initiation (Sonenberg, 1996). Two phos-
phoproteins that are currently thought to be involved in subset of mRNAs, the role of S6 phosphorylation ap-
pears not to be a general requirement for translation.the regulation of this complex of factors are the eIF4E
binding proteins, 4E-BP1 and 4E-BP2. When in the de- On these lines, it has been speculated that S6 phosphor-
ylation is involved in the regulated translation of mRNAsphosphorylated form, 4E-BPs bind directly to eIF4E and
competitively inhibit association of eIF4G with eIF4E, an that contain 59 TOP elements (Jefferies et al., 1994; Ter-
ada et al., 1994).effect that is implied to prevent the assembly of the
helicase complex on mRNA (for further review see So- Although together these studies can be constructed
into attractive models, a great deal of research into thenenberg, 1996). Growth factors are known to stimulate
the phosphorylation of 4E-BP1 and cause its dissocia- role of S6 and 4E-BP phosphorylation in translation reg-
ulation is still required. For example, it has been sug-tion from eIF4E (Figure 1). Recently, two groups have
reported that rapamycin potently inhibits the serum- gested that eIF4E is necessary for cap-dependent trans-
lation, a process that involves the translation of mostinduced phosphorylation of 4E-BP1 (Beretta et al., 1996
and references therein). Consistent with the inability of eukaryotic mRNA. Furthermore, the relationship be-
tween secondary structure and 4E-BPs as well as thatrapamycin to inhibit activation of MAP kinase and rsk,
this phosphorylation is independent of the ras/MAP ki- between 59 TOP elements and S6 phosphorylation are
preliminary models that are currently under research. Itnase pathway (von Manteuffel et al., 1996). Thus, the
translational events that are dependent on the rapa- is not known whether regulation through these ele-
ments, or ones that have yet to be identified, may func-mycin-sensitive signaling pathway may be regulated in
part through the phosphorylation of 4E-BPs. tion in a rapamycin-sensitive pathway or whether the
storage and removal of mRNAs from RNP particles mayHowever, 4E-BP1 is not the only connection between
the rapamycin-sensitive signaling pathway and transla- also play a role. Finally, it is possible that there are
other rapamycin-sensitive factors that are involved intional regulation. Another rapamycin-sensitive mediator
of signaling pathways stimulated by growth factors is the translation of the rapamycin-sensitive mRNAs de-
scribed earlier in this review. Nevertheless, the observedthe serine/threonine kinase p70S6k. Phosphorylation and
activation of this kinase leads to the phosphorylation of effects of rapamycin on both translation and on factors
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such as 4EBP1and p70S6k describes a signaling pathway to regulate G1 progression througha translationalmech-
anism (Barbet et al., 1996). Although little is known ofthat emanates from growth factor receptors and leads
how this regulation occurs, cell cycle progression in S.to translational control. Since rapamycin is a specific
cerevisiae does not appear to require the phosphoryla-inhibitor of this pathway, the molecule rapamycin inhib-
tion of S6 since mutation of the phosphorylation sitesits must in some way regulate each of these growth
in the yeast S6 protein (S10) does not hinder proliferationfactor-stimulated effects.
(Johnson and Warner, 1987). It may bethat S6 phosphor-A Growth Factor Regulated Signaling
ylation functions differently in yeast than in mammals,Pathway for Translational Control
since a heat shock stimulus has opposite effects on theThe inhibitory effects of rapamycin on cellcycle progres-
phosphorylation state of S6 in these cells.sion and translation are contingent first uponan associa-
Recent studies have shown that regulated translationtion of rapamycin with the intracellular protein FKBP12
functions in modulating the activity of cyclin-dependent(reviewed by Chou and Blenis, 1995). It is now known
kinases in mammalian cells. It has recently been re-that formation of this FKBP12–rapamycin complex pro-
ported that the change in expression of the cyclin-vides a high affinity inhibitor of a 289 kd protein termed
dependent kinase inhibitor p27KIP1 following treatmentFRAP or RAFT1 (for FKBP12-rapamycin associated pro-
with PDGF or lovastatin is mediated through an alteredtein or rapamycin and FKBP12 target, respectively).
rate of translation of the encoding mRNA (Agrawal etFRAP is a member of a newly discovered family of phos-
al., 1996; Hengst and Reed, 1996). Since the mitogen-phatidylinositol kinases-related kinases (PIK-related ki-
stimulated activity of cyclin-dependent kinases is sensi-nases) involved in events ranging from cell cycle reg-
tive to rapamycin treatment (Nourse et al., 1994, andulation in response to stress to DNA recombination
references therein), it is possible that FRAP is on the(reviewed by Keith and Schreiber, 1995). Although the
pathway to the regulated translation of cyclin-depen-biochemical regulation and function of FRAP is not com-
dent kinase inhibitors. Consistent with this model, treat-pletely understood, FRAP has an intrinsic protein kinase
ment of T lymphocytes with interleukin-2 modulates theactivity as evidenced by its ability to autophosphorylate
levels of the cyclin-dependent kinase inhibitors p21CIP1on a serine residue in vitro (Brown, et al., 1995). Further-
and p27KIP1 in a rapamycin-sensitive fashion (Nourse etmore, FRAP has recently been shown to regulate p70S6k
al., 1994). In the case of p21CIP1, this regulation occursactivation in vivo in a manner that is dependent on both
without alteration of the levels of the encoding mRNA.
the kinase activity of FRAP and on an N-terminal domain
It will be important todetermine if the effect of rapamycin
(Brown et al., 1995). As implied by rapamycin-sensitivity,
on p21CIP1 and p27KIP1 expression is through regulated
it is likely that 4E-BP1 phosphorylation is also regulated
translation, thus placing p21CIP1 and p27KIP1 among the
by FRAP. No interaction with or phosphorylation of other specific rapamycin-sensitive transcripts. Identifi-
p70S6k or 4E-BP1 by FRAP has been observed, suggest-
cation of the elements within 59 UTRs of the rapamycin-
ing the existence of as yet unidentified components of sensitive transcripts and discovery of other intermediate
this pathway. These studies suggest a role for FRAP in molecules involved in this signaling pathway will be nec-
the pathway leading to the phosphorylation of both S6 essary to provide a complete link between growth factor
and 4E-BP1 and to the regulated translation of a subset signaling and the activation of cyclin-dependent ki-
of mRNA transcripts. nases.
Early signaling events that are involved in p70S6k and Feedback Regulation of Translation by Inhibitors
4E-BP1 regulation have been further elucidated through of Translation Elongation
the use of a potent inhibitor of phosphatidylinositol- Growth factors however are not the only mechanism
3-kinase (PI3K), wortmannin (Chou and Blenis, 1995). available to activate this rapamycin-sensitve signaling
Treatment of cells with wortmannin prevents the growth pathway. It has been known for over 20 years that small
factor-regulated increase in p70S6k activity (Chou and molecule inhibitors of protein translation, like cyclohexi-
Blenis, 1995) and 4E-BP1 phosphorylation (von Man- mide and puromycin, also cause the phosphorylation of
teuffel et al., 1996). In addition, evidence in support of S6 in vivo (Gressner and Wool, 1974). More recently,
PI3K as an upstream regulator of p70S6k and 4E-BP1 has anisomycin and cycloheximide treatment have been
been derived from studies using mutants of the PDGF shown to activate p70S6k in a rapamycin-sensitive fash-
receptor and of IRS-1, respectively (Mendez et al., 1996; ion (references within Nielsen et al., 1995, and Chou and
reviewed by Chou and Blenis, 1995). Although it is not Blenis, 1995) and cause the phosphorylation of 4E-BP1
currently clear how the signal is propagated from PI3K (von Manteuffel et al., 1996). Interestingly, treatment of
to p70S6k and 4E-BP1, FRAP does not appear to be chick embryo fibroblasts with cycloheximide at concen-
upstream of PI3K (Chou and Blenis, 1995). In addition, trations that only partially inhibit elongation causes an
phospholipase C-g (PLCg) and the protein kinases PKC overall increase in the rate of synthesis of ribosomal
and Akt have been implied to have some function in this proteins, some of the same proteins whose translation is
pathway (Chou and Blenis, 1995). Thus, the outline of a activated by growth factors and inhibited by rapamycin
growth factors-regulated signaling pathway that leads (Ignotz et al., 1981). In addition, the small molecule ani-
to translational control is beginning to emerge and is somycin causes a 2-3 fold increase in the association
distinct from the now familiar MAP kinase pathway (Fig- of eEF1A and IGF-II (6.0 kb variant) mRNAs with polyri-
ure 1). bosomes (Nielsen et al., 1995). Overall, these results
It is possible rapamycin’s effects on translation are suggest that, inaddition to a pathway initiated by growth
responsible for its ability to inhibit G1 cell cycle progres- factor receptors, an intracellular signaling cascade ema-
sion. In accord with such a hypothesis, the S. cerevisiae nating from the protein synthesis machinery itself in-
duces translational events that are rapamycin-sensitive.homologs of FRAP, TOR1, and TOR2, are now thought
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MEC1 is an S. cerevisiae gene product that is homolo-
gous to FRAP and regulates the cell cycle progression
in response to conditions that retard DNA synthesis,
such as depletion of deoxyribonucleotides (Sanchez et
al., 1996, and references therein). Other than regulating
S phase progression, MEC1 responds to the depletion
of deoxyribonucleotides (via hydroxyurea treatment) by
mediating a signaling pathway that induces the expres-
sion of ribonucleotide reductase, an enzyme involved in
the biosynthesis of deoxyribonucleic acids. This signal-
ing pathway, which is just beginning to be understood,
is strikingly similar to the activation of the FRAP/p70S6k
pathway that is initiated by inhibitors of translation elon-
gation (Figure 2). In analogy to the MEC1-mediated
upregulation of ribonucleotide reductase in response
to depletion of deoxyribonucleotides, FRAP appears to
mediate an increase in the translation of ribosomal pro-
teins in response to inhibition of the 60S ribosomal sub-
unit. Thus, in addition to an involvement in growth fac-
tor–regulated events, these feedback pathways suggest
a sensory role for FRAP analogous to that of MEC1. The
implication of FRAP in this process and in the control
of translation and cell cycle progression providesoppor-
tunities for further research in areas that are just begin-
ning to emerge.
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